BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30215611)

  • 21. Microfluidic Manufacture of Lipid-Based Nanomedicines.
    Osouli-Bostanabad K; Puliga S; Serrano DR; Bucchi A; Halbert G; Lalatsa A
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital Microfluidics for Manipulation and Analysis of a Single Cell.
    He JL; Chen AT; Lee JH; Fan SK
    Int J Mol Sci; 2015 Sep; 16(9):22319-32. PubMed ID: 26389890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microfluidics: a transformational tool for nanomedicine development and production.
    Garg S; Heuck G; Ip S; Ramsay E
    J Drug Target; 2016 Nov; 24(9):821-835. PubMed ID: 27492254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities.
    Agrahari V; Agrahari V
    Drug Discov Today; 2018 May; 23(5):974-991. PubMed ID: 29406263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microfluidic chip interfacing microdialysis and mass spectrometry for in vivo monitoring of nanomedicine pharmacokinetics in real time.
    Chen Y; Yang Y; Zeng X; Feng JL; Oakes K; Zhang X; Cui S
    J Chromatogr A; 2022 Nov; 1683():463520. PubMed ID: 36209679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microfluidic platforms for advanced risk assessments of nanomaterials.
    Mahto SK; Charwat V; Ertl P; Rothen-Rutishauser B; Rhee SW; Sznitman J
    Nanotoxicology; 2015 May; 9(3):381-95. PubMed ID: 25051329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microdevices for nanomedicine.
    Hashimoto M; Tong R; Kohane DS
    Mol Pharm; 2013 Jun; 10(6):2127-44. PubMed ID: 23521558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in nanomedicines for the treatment of rheumatoid arthritis.
    Wang Q; Sun X
    Biomater Sci; 2017 Jul; 5(8):1407-1420. PubMed ID: 28631779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Materials for Microfluidic Immunoassays: A Review.
    Mou L; Jiang X
    Adv Healthc Mater; 2017 Aug; 6(15):. PubMed ID: 28322517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications.
    Mark D; Haeberle S; Roth G; von Stetten F; Zengerle R
    Chem Soc Rev; 2010 Mar; 39(3):1153-82. PubMed ID: 20179830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Droplet-based microfluidic platforms for the encapsulation and screening of Mammalian cells and multicellular organisms.
    Clausell-Tormos J; Lieber D; Baret JC; El-Harrak A; Miller OJ; Frenz L; Blouwolff J; Humphry KJ; Köster S; Duan H; Holtze C; Weitz DA; Griffiths AD; Merten CA
    Chem Biol; 2008 May; 15(5):427-37. PubMed ID: 18482695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidics for cell-based high throughput screening platforms - A review.
    Du G; Fang Q; den Toonder JM
    Anal Chim Acta; 2016 Jan; 903():36-50. PubMed ID: 26709297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in microfluidic cell culture systems for studying angiogenesis.
    Young EW
    J Lab Autom; 2013 Dec; 18(6):427-36. PubMed ID: 23832929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inertial microfluidics.
    Di Carlo D
    Lab Chip; 2009 Nov; 9(21):3038-46. PubMed ID: 19823716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Droplet-based Biosensing for Lab-on-a-Chip, Open Microfluidics Platforms.
    Dak P; Ebrahimi A; Swaminathan V; Duarte-Guevara C; Bashir R; Alam MA
    Biosensors (Basel); 2016 Apr; 6(2):14. PubMed ID: 27089377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grand challenges in modulating the immune response with RNAi nanomedicines.
    Goldsmith M; Mizrahy S; Peer D
    Nanomedicine (Lond); 2011 Dec; 6(10):1771-85. PubMed ID: 22122585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microfluidic-Mass Spectrometry Interfaces for Translational Proteomics.
    Pedde RD; Li H; Borchers CH; Akbari M
    Trends Biotechnol; 2017 Oct; 35(10):954-970. PubMed ID: 28755975
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.